These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35948307)

  • 1. Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk.
    Goss A
    Med J Aust; 2022 Sep; 217(5):268. PubMed ID: 35948307
    [No Abstract]   [Full Text] [Related]  

  • 2. Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk.
    Stuckey BG; Khatri NS
    Med J Aust; 2022 Sep; 217(5):268. PubMed ID: 35948314
    [No Abstract]   [Full Text] [Related]  

  • 3. Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk.
    Shrestha Khatri N; Stuckey BG
    Med J Aust; 2022 Apr; 216(6):283-284. PubMed ID: 35267213
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation: A Report of Two Cases.
    Anagnostis P; Paschou SA; Gonzalez-Rodriguez E; Potoupnis M; Tsiridis E; Lamy O; Goulis DG
    J Clin Rheumatol; 2021 Dec; 27(8S):S581-S584. PubMed ID: 30614889
    [No Abstract]   [Full Text] [Related]  

  • 5. Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates.
    Tripto-Shkolnik L; Rouach V; Marcus Y; Rotman-Pikielny P; Benbassat C; Vered I
    Calcif Tissue Int; 2018 Jul; 103(1):44-49. PubMed ID: 29396698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping Denosumab.
    Lamy O; Stoll D; Aubry-Rozier B; Rodriguez EG
    Curr Osteoporos Rep; 2019 Feb; 17(1):8-15. PubMed ID: 30659428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound-associated vertebral fractures after stopping denosumab: Report of four cases.
    Dupont J; Laurent MR; Dedeyne L; Luyten FP; Gielen E; Dejaeger M
    Joint Bone Spine; 2020 Mar; 87(2):171-173. PubMed ID: 31369866
    [No Abstract]   [Full Text] [Related]  

  • 8. Dilemma of denosumab therapy: rebound fractures with denosumab cessation or dose delay.
    Herath M; Wong P; Milat F
    Intern Med J; 2021 Feb; 51(2):297-298. PubMed ID: 33631850
    [No Abstract]   [Full Text] [Related]  

  • 9. Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Kono T; Sudo A
    Osteoporos Int; 2018 Mar; 29(3):769-772. PubMed ID: 29230512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Rebound-Associated Vertebral Fractures after Denosumab Discontinuation: Is Prompt Antiresorptive Therapy Always Recommended,Even When the Risk of Fracture Seems Low? A Case Report.
    Osella G; Puglisi S; Alì A; Reimondo G; Terzolo M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2303-2306. PubMed ID: 34238202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?].
    Gonzalez Rodriguez E; Lamy O; Aubry-Rozier B; Stoll D; Uebelhart B
    Rev Med Suisse; 2019 Apr; 15(647):831-835. PubMed ID: 30994986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.
    Fu SH; Wang CY; Hung CC; Lee CC; Yang RS; Huang CC; Farn CJ; Lin WH; Chen HM; Hsiao FY; Lin JW; Li CY
    J Intern Med; 2021 Dec; 290(6):1194-1205. PubMed ID: 34237171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
    Aubry-Rozier B; Gonzalez-Rodriguez E; Stoll D; Lamy O
    Osteoporos Int; 2016 May; 27(5):1923-5. PubMed ID: 26510845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The denosumab dilemma: to be stopped after 5 years or to be continued in patients with osteoporosis?].
    Wolffenbuttel BHR; Abma EM; Appelman-Dijkstra NM
    Ned Tijdschr Geneeskd; 2018 May; 162():. PubMed ID: 30040306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second rebound-associated vertebral fractures after denosumab discontinuation.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Kono T; Sudo A
    Arch Osteoporos; 2020 Jan; 15(1):7. PubMed ID: 31898803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple vertebral fractures after denosumab discontinuation].
    Tjelum L; Eiken P
    Ugeskr Laeger; 2018 Nov; 180(45):. PubMed ID: 30404716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical vertebral fractures following denosumab discontinuation.
    Polyzos SA; Terpos E
    Endocrine; 2016 Oct; 54(1):271-272. PubMed ID: 27393301
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
    Lamy O; Gonzalez-Rodriguez E; Aubry-Rozier B
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2112. PubMed ID: 28586456
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
    Rao SD; Qiu S; Dhaliwal R; Bhadada SK
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2111. PubMed ID: 28586451
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple vertebral fractures after suspension of denosumab. A series of 56 cases.
    Sosa-Henríquez M; Torregrosa O; Déniz A; Saavedra P; Ortego N; Turrión A; Pérez Castrillón JL; Díaz-Curiel M; Gómez-Alonso C; Martínez G; Antonio Blázquez J; Olmos-Martínez JM; Etxebarria Í; Caeiro JR; Mora-Peña D
    Int J Clin Pract; 2021 Oct; 75(10):e14550. PubMed ID: 34145944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.